Key questions on ovarian and breast cancer genetics (1.5 CPD hours)
23 May 2014
FULL CPD MODULE
This module will update your knowledge on ovarian and breast cancer genetics, including:
- The reliability of negative genetic testing
- Risk reduction strategies that moderate/high-risk women should consider
- The implications regarding contraception and HRT for women at high or moderate risk
- Who should be considered for chemoprevention or prophylactic mastectomy
- Who would warrant genetic testing for the BRCA1 or BRCA2 gene
Visit Pulse Reference for details on 140 symptoms, including easily searchable symptoms and categories, offering you a free platform to check symptoms and receive potential diagnoses during consultations.
